369 results on '"Kestin, Larry L."'
Search Results
2. Predictors of Early Hospice or Death in Patients With Inoperable Lung Cancer Treated With Curative Intent
3. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative
4. Cardiac and Pulmonary Dosimetric Parameters in Patients With Lung Cancer Undergoing Postoperative Radiation Therapy Across a Statewide Consortium
5. Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium
6. American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020
7. American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC
8. Stereotactic Image Guided Lung Radiation Therapy for Clinical Early Stage Non-Small Cell Lung Cancer: A Long-Term Report From a Multi-Institutional Database of Patients Treated With or Without a Pathologic Diagnosis
9. Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium
10. Predictors of Early Hospice or Death in Patients with Inoperable Lung Cancer Treated with Curative Intent
11. ACR Appropriateness Criteria Non-invasive Clinical Staging of Bronchogenic Carcinoma
12. Pathologic Anatomy of Early-Stage Breast Cancer and Its Relevance to APBI: Defining the Target
13. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients
14. Pathologic Anatomy of Early-Stage Breast Cancer and its Relevance to Accelerated Partial Breast Irradiation: Defining the Target
15. ACR Appropriateness Criteria Nonsurgical Treatment for Non–Small-Cell Lung Cancer: Poor Performance Status or Palliative Intent
16. Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals
17. A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy
18. Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?
19. Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial
20. Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors
21. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer
22. PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation
23. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis
24. American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer
25. Determinants of intrafraction variation during image-guided hypofractionated radiotherapy of the prostate
26. Twenty-Year Outcomes after Breast-Conserving Surgery and Definitive Radiotherapy for Mammographically Detected Ductal Carcinoma In Situ
27. A Multi-Institutional Matched-Control Analysis of Adjuvant and Salvage Postoperative Radiation Therapy for pT3-4N0 Prostate Cancer
28. Optimal Use of Re-Excision in Patients Diagnosed with Early-Stage Breast Cancer by Excisional Biopsy Treated with Breast-Conserving Therapy
29. Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: a long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis
30. Long-Term Impact of Young Age at Diagnosis on Treatment Outcome and Patterns of Failure in Patients with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy
31. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma
32. Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: a long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis
33. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution
34. Accelerated Treatment of Breast Cancer
35. Radiation Endocrine Action in Prostate Cancer
36. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast
37. Matched-Pair Analysis of Conformal High–Dose-Rate Brachytherapy Boost Versus External-Beam Radiation Therapy Alone for Locally Advanced Prostate Cancer
38. Impact of Young Age on Outcome in Patients With Ductal Carcinoma-In-Situ Treated With Breast-Conserving Therapy
39. Treatment of Ductal Carcinoma in Situ
40. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age
41. The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma
42. Prostatectomy, External Beam Radiation Therapy, or Brachytherapy for Localized Prostate Cancer
43. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy
44. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution
45. Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy
46. Percentage of Positive Biopsy Cores as Predictor of Clinical Outcome in Prostate Cancer Treated With Radiotherapy.
47. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer
48. ACR appropriateness criteria[R]: nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent
49. ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer
50. Determinants of change of prostate-specific antigen over time and its association with recurrence following external beam radiation therapy of prostate cancer in 5 large cohorts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.